Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEP) Return on Capital Employed (2021 - 2025)

Coeptis Therapeutics Holdings (COEP) has 5 years of Return on Capital Employed data on record, last reported at 1.26% in Q3 2025.

  • For Q3 2025, Return on Capital Employed fell 316.0% year-over-year to 1.26%; the TTM value through Sep 2025 reached 1.26%, down 316.0%, while the annual FY2024 figure was 4.52%, 318.0% down from the prior year.
  • Return on Capital Employed reached 1.26% in Q3 2025 per COEP's latest filing, up from 1.54% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 9.43% in Q1 2024 and bottomed at 2.61% in Q4 2023.
  • Average Return on Capital Employed over 5 years is 1.16%, with a median of 0.54% recorded in 2021.
  • Peak YoY movement for Return on Capital Employed: soared 844bps in 2023, then crashed -1145bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.36% in 2021, then soared by 275bps to 0.63% in 2022, then tumbled by -511bps to 2.61% in 2023, then increased by 13bps to 2.28% in 2024, then surged by 45bps to 1.26% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 1.26% in Q3 2025, 1.54% in Q2 2025, and 2.02% in Q1 2025.